731803-26-2

Upstream product

• 67-56-1 methanol 
• 700832-43-5 3'-[4-benzyloxy-3-methylphenyl]-3'-[4-trifluoromethylsulfonyloxy-3-methylphenyl]pentane 
• 201230-82-2 carbon monoxide 

Downstream Products

• 853404-22-5 3'-[4-benzyloxy-3-methylphenyl]-3'-[4-carboxyl-3-methylphenyl]pentane 
• 731803-28-4 3'-[4-benzyloxy-3-methylphenyl]-3'-[4-hydroxymethyl-3-methylphenyl]pentane 

Relevant academic research and scientific papers

Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators

The present invention relates to a method of treating or preventing damage to human skin cells by chemical vesicants by administering a non-secosteroidal, diphenyl compound with vitamin D receptor (VDR) modulating activity.

VITAMIN D RECEPTOR MODULATORS

The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis. X-15439

VITAMIN D RECEPTOR MODULATORS

The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1a,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.